WoundCentrics, LLC – Trademark Portfolio
Entity Type: 16
WoundCentrics, LLC has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as WOUNDCENTRICS and WOUND CARE UNIVERSITY. Filings span 3 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 41 (Education & Entertainment). This trademark owner is based in Lubbock, TX.
5224 75th Street, Suite D
Lubbock, TX 79424
Showing of trademarks Trademarks
Trademark Classifications
WoundCentrics, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does WoundCentrics, LLC have?
WoundCentrics, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does WoundCentrics, LLC file in?
WoundCentrics, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are WoundCentrics, LLC's most well-known trademarks?
WoundCentrics, LLC's registered trademark portfolio includes well-known marks such as WOUNDCENTRICS and WOUND CARE UNIVERSITY. These are among 2 currently registered trademarks in the portfolio.
What is WoundCentrics, LLC's trademark registration success rate?
WoundCentrics, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.